Gene therapy for hemophilia represents a groundbreaking advancement in the management and treatment of this hereditary bleeding disorder.With recent innovations such as Hemgenix, patients now have the potential to replace the missing clotting factor with a single treatment, alleviating the need for frequent clotting factor replacement.